BlackRock’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $382K | Sell |
|
|||||
|
2025
Q2 | $350K | Sell |
|
|||||
|
2025
Q1 | $805K | Sell |
|
|||||
|
2024
Q4 | $1.36M | Buy |
|
|||||
|
2024
Q3 | $2.19M | Sell |
|
|||||
|
2024
Q2 | $4.07M | Sell |
|
|||||
|
2024
Q1 | $5.2M | Buy |
|
|||||
|
2023
Q4 | $4.68M | Buy |
|
|||||
|
2023
Q3 | $3.3M | Buy |
|
|||||
|
2023
Q2 | $3.87M | Buy |
|
|||||
|
2023
Q1 | $2.41M | Buy |
|
|||||
|
2022
Q4 | $2.38M | Sell |
|
|||||
|
2022
Q3 | $3.03M | Sell |
|
|||||
|
2022
Q2 | $2.76M | Sell |
|
|||||
|
2022
Q1 | $7.26M | Buy |
|
|||||
|
2021
Q4 | $11.2M | Buy |
|
|||||
|
2021
Q3 | $22.7M | Buy |
|
|||||
|
2021
Q2 | $20.1M | Buy |
|
|||||
|
2021
Q1 | $29.5M | Buy |
|
|||||
|
2020
Q4 | $45.6M | Buy |
|
|||||
|
2020
Q3 | $1.88M | Buy |
|